AI-powered search
Try Polaris, our new AI-powered search!

Are there any contraindications or precautions dermatologists should consider before beginning a patient on ruxolitinib for vitiligo?

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published July 01, 2024